129 related articles for article (PubMed ID: 21206339)
1. Lipoprotein apheresis.
Thompson GR
Curr Opin Lipidol; 2010 Dec; 21(6):487-91. PubMed ID: 21206339
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017.
Pottle A; Thompson G; Barbir M; Bayly G; Cegla J; Cramb R; Dawson T; Eatough R; Kale V; Neuwirth C; Nicholson K; Payne J; Scott J; Soran H; Walji S; Watkins S; Weedon H; Nath Datta DB
Atherosclerosis; 2019 Nov; 290():44-51. PubMed ID: 31563836
[TBL] [Abstract][Full Text] [Related]
3. Severe dyslipidemia in pregnancy: The role of therapeutic apheresis.
Russi G
Transfus Apher Sci; 2015 Dec; 53(3):283-7. PubMed ID: 26626968
[TBL] [Abstract][Full Text] [Related]
4. The evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular disease.
Thompson GR
Atheroscler Suppl; 2013 Jan; 14(1):67-70. PubMed ID: 23357143
[TBL] [Abstract][Full Text] [Related]
5. Familial Hypercholesterolaemia Regression Study and its implications.
Watts GF
Lancet; 1995 Apr; 345(8953):807-8. PubMed ID: 7898224
[No Abstract] [Full Text] [Related]
6. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
Thiery J; Seidel D
Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
[TBL] [Abstract][Full Text] [Related]
7. Acute effect of a single session of lipoprotein apheresis on central haemodynamics in patients with familial hypercholesterolaemia.
Ellins EA; Watkins S; Rees DA; Datta DBN; Halcox JP
Atherosclerosis; 2021 May; 325():121-123. PubMed ID: 33883085
[No Abstract] [Full Text] [Related]
8. Indications for apheresis as an ultima ratio treatment of refractory hyperlipidemias.
Grützmacher P; Kleinert C; Dorbath C; Öhm B
Clin Res Cardiol Suppl; 2015 Apr; 10(Suppl 1):2-7. PubMed ID: 25686595
[TBL] [Abstract][Full Text] [Related]
9. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia].
Lasunción MA; Teruel JL; Alvarez JJ; Gómez-Coronado D; Ortuño J; Herrera E
Med Clin (Barc); 1992 Oct; 99(14):541-4. PubMed ID: 1434990
[TBL] [Abstract][Full Text] [Related]
10. Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis.
McGowan MP
J Clin Lipidol; 2013; 7(3 Suppl):S21-6. PubMed ID: 23642325
[TBL] [Abstract][Full Text] [Related]
11. [Reducing low density lipoprotein-cholesterol levels by apheresis].
Reiber I; Gógl A
Orv Hetil; 1994 Mar; 135(11):563-8. PubMed ID: 8159408
[TBL] [Abstract][Full Text] [Related]
12. Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels.
Schettler VJ; Neumann CL; Peter C; Zimmermann T; Julius U; Roeseler E; Heigl F;
Clin Res Cardiol Suppl; 2015 Apr; 10(Suppl 1):14-20. PubMed ID: 25652812
[TBL] [Abstract][Full Text] [Related]
13. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
Lee WP; Datta BN; Ong BB; Rees A; Halcox J
Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresis.
Blaha M; Lanska M; Blaha V; Boudys L; Zak P
Atheroscler Suppl; 2015 May; 18():134-9. PubMed ID: 25936317
[TBL] [Abstract][Full Text] [Related]
15. Efficacy criteria and cholesterol targets for LDL apheresis.
Thompson GR; Barbir M; Davies D; Dobral P; Gesinde M; Livingston M; Mandry P; Marais AD; Matthews S; Neuwirth C; Pottle A; le Roux C; Scullard D; Tyler C; Watkins S
Atherosclerosis; 2010 Feb; 208(2):317-21. PubMed ID: 19589528
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia.
Vella A; Pineda AA; O'Brien T
Mayo Clin Proc; 2001 Oct; 76(10):1039-46. PubMed ID: 11605688
[TBL] [Abstract][Full Text] [Related]
17. [Selection criteria for treatment of severe hyperlipoproteinemias with LDL apheresis].
Bláha V; Zadák Z; Bláha M; Havel E; Solichová D; Brátová M; Malý J; Kmonícek L
Cas Lek Cesk; 1998 Jul; 137(14):424-9. PubMed ID: 9748737
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia.
Meier P; Blanc E
Nephrol Dial Transplant; 2000 May; 15(5):738-40. PubMed ID: 10809830
[No Abstract] [Full Text] [Related]
19. [LDL-Apheresis for the treatment of hyperchylomicronemia-induced pancreatitis].
Sattler AM; Bock K; Schmidt S; Maisch B; Schaefer JR
Z Kardiol; 2003; 92(Suppl 3):III64-7. PubMed ID: 14663605
[TBL] [Abstract][Full Text] [Related]
20. Hypertriglyceridemic pancreatitis: presentation and management.
Tsuang W; Navaneethan U; Ruiz L; Palascak JB; Gelrud A
Am J Gastroenterol; 2009 Apr; 104(4):984-91. PubMed ID: 19293788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
